Evidence map›Paper›PMID 40053176›Full record

ArticleAnnals of nuclear medicine2025

Insights into lung cancer diagnosis and clinical management using [

Xingyu Mu, Zhuohao Zhu, Zhenzhen Wang, Xiaotian Li, Yang Wu, Jingze Li, Lei Zhang, Wei Fu

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Diagnostic performance of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingyu Mu *Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.
Zhuohao Zhu *Department of Oncology, The Second Affiliated Hospital of Guilin Medical University, No.212 Renmin Road, Lingui District, Guilin, 541199, Guangxi Zhuang Autonomous Region, China.
Zhenzhen WangDepartment of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.
Xiaotian LiDepartment of Radiology, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.
Yang WuDepartment of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.
Jingze LiDepartment of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China.
Lei ZhangDepartment of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China. 463173891@qq.com.
Wei FuDepartment of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin, 541001, Guangxi Zhuang Autonomous Region, China. fuwei19700513@163.com.

Funding

National Natural Science Foundation of China 82402332National Natural Science Foundation of China 82460356
6 · The paper itself

Abstract

purposeAccurate diagnosis and staging of lung cancer are critical for optimal clinical management. Fibroblast activation protein inhibitor (FAPI) imaging has emerged as a promising modality with superior detection capabilities for lung cancer. We hypothesized that [

methodsIn this retrospective study, 155 patients with clinically suspected or confirmed lung cancer underwent both conventional imaging and [

resultsOf the 155 patients, 99 were evaluated for primary lesion diagnosis and staging. Pathological examination confirmed malignant tumors in 87 patients and benign tumors in 12. The diagnostic sensitivity and positive predictive value of [

conclusion[

Indexed as

Lung NeoplasmsMembrane ProteinsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesMembrane Proteins[18F]FAPI-42Clinical managementLung cancerPET/CTTNM staging

Identifiers

PMID40053176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.